Compounded tirzepatide: programs, prices, and evidence
Compounded tirzepatide is a pharmacy-prepared version of the active ingredient in FDA-approved medications; the compounded product itself is not FDA approved and is not a generic. This hub separates the 17 captured tirzepatide programs by dosage form — injection (standard-dose and microdose); ODT/sublingual — and by standard-dose versus microdose, each with its own evidence status and 2026-07-20 verification date. No formulation's evidence transfers to another, and no affordability winner is published pending checkout verification.
Provider price comparison
Lowest captured: NexLife at $186.00; highest: Ready Med at $449.00. Bar colour reflects evidence status. All figures provider-reported or calculated, not checkout-verified.
View chart data as a table
| Provider | $ effective monthly | Evidence status |
|---|---|---|
| NexLife | $186.00 | PROVIDER REPORTED |
| Join Josie | $233.00 | PROVIDER REPORTED |
| Mochi Health | $278.00 | PROVIDER REPORTED |
| Eden | $298.00 | CALCULATED |
| Ready Med | $449.00 | PROVIDER REPORTED |
Live from the program database. Provider-reported or calculated figures, not checkout-verified. Full detail on the price comparison page.
Price comparison
Standard-dose injection programs, normalized to effective monthly cost with membership fees included.
Microdose programs
Separate category; standard-dose trial evidence does not transfer.
Oral, ODT & sublingual
Different formulations with uncharacterized absorption; never ranked against injections.
Is compounded tirzepatide FDA approved?
Direct answer with the regulatory basis.
What the captured data shows (2026-07-20)
Every figure below is Provider Reported or pending verification — see each program's table for status, source, and caveats. Programs span month-to-month billing and prepaid commitments; a monthly equivalent never means monthly billing.
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $215 | $215.00 | $215 | — |
| 3 months prepaid | $585 | $195.00 | $195 | $60 |
| 6 months prepaid | $1,140 | $190.00 | $190 | $150 |
| 12 months prepaid | $2,232 | $186.00 | $186 | $348 |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $189 | $189.00 | $189 | — |
| 3 months prepaid | $477 | $159.00 | — | $88 |
| 6 months prepaid | $900 | $150.00 | — | $235 |
| 12 months prepaid | $1,764 | $147.00 | $147 | $504 |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $229 | $229.00 | $229 | — |
| 3 months prepaid | $657 | $219.00 | $219 | $30 |
| 6 months prepaid | $1,230 | $205.00 | $205 | $144 |
| 12 months prepaid | $2,388 | $199.00 | $199 | $360 |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $278 | $278.00 | $199 | — $199/mo medication + $79/mo membership; all-in independently calculated. |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $298 | $298.00 | $199 | — $199/mo medication + $99/mo membership; all-in independently calculated. |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 3 months prepaid | $1,047 | $349.00 | $349 | — Advertised prepaid promotion $891 ($297/mo) may apply; promotional price excluded from recurring comparison. |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $359 | $359.00 | $359 | — Advertised 'about $359' |
| 12 months prepaid | $2,880 | $240.00 | $240 | — ~$240/mo annual; total independently estimated |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $349 | $349.00 | $349 | — |
| 3 months prepaid | $798 | $266.00 | $266 | — Total independently calculated |
| 6 months prepaid | $1,500 | $250.00 | $250 | — Total independently calculated |
| 12 months prepaid | $2,796 | $233.00 | $233 | — Total independently calculated |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $349 | $349.00 | $349 | — |
| 3 months prepaid | $900 | $300.00 | $300 | — |
| 6 months prepaid | $1,602 | $267.00 | $267 | — |
| 12 months prepaid | $2,904 | $242.00 | $242 | — |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $189 | $189.00 | $189 | — |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $329 | $329.00 | $329 | — 'About $329' |
| 3 months prepaid | $765 | $255.00 | $255 | — Total independently calculated |
| 6 months prepaid | $1,428 | $238.00 | $238 | — Total independently calculated |
| 12 months prepaid | $2,820 | $235.00 | $235 | — Total independently calculated |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 2 months prepaid | $700 | $350.00 | — | — $550 + 2 x ~$75 membership, independently calculated |
| 4 months prepaid | $1,200 | $300.00 | — | — $900 + 4 x ~$75 membership, independently calculated |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 6 months prepaid | $1,248 | $208.00 | — | — ~$133/mo medication + ~$75/mo membership, independently estimated |
| 4 months prepaid | $896 | $224.00 | — | — ~$149 + ~$75 membership |
| 2 months prepaid | $550 | $275.00 | — | — ~$200 + ~$75 membership |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $449 | $449.00 | $449 | — $349 first month (introductory); recurring $449 shown |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $349 | $349.00 | $349 | — $249 first month (introductory); recurring $349 shown |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $399 | $399.00 | $399 | — 'About $399' reported all-inclusive |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $299 | $299.00 | $299 | — Monthly plan; no separate membership. Advertised=checkout in third-party testing (2026). |
What compounded tirzepatide is
Tirzepatide is the active ingredient in a class of medications that act on GLP-1 receptors to reduce appetite and slow gastric emptying, producing weight loss and, in the approved products, improvements in blood sugar and other outcomes. Compounded tirzepatide is that same active ingredient prepared by a compounding pharmacy rather than manufactured as an FDA-approved product. The distinction is not cosmetic: a compounded preparation is made outside the premarket-review system, its quality depends on the individual pharmacy, and its formulation, concentration, and any added ingredients can vary. It is not a generic of any approved product — generics are themselves FDA-approved and demonstrated to match the reference product, which compounded preparations are not.
How it differs from the FDA-approved products
The approved tirzepatide products went through review of manufacturing consistency, labeling, and clinical evidence before they could be marketed; compounded tirzepatide did not. That gap has three practical consequences. First, the clinical-trial results that support the approved products belong to those specific products at their studied doses and don't automatically describe a compounded preparation's effect. Second, quality assurance shifts from a manufacturer's validated process to the individual pharmacy's practices, which is why verifying the pharmacy matters. Third, availability is now legally narrower: with the tirzepatide shortage resolved, mass-marketed compounding faces significant federal restrictions, and access generally depends on a prescriber documenting a patient-specific clinical need rather than broad marketing. Whether a given prescription meets that standard is a case-specific medical and legal question this publication doesn't decide.
Dosage forms and why they're separated
The captured tirzepatide programs span more than one delivery route, and this hub keeps them separate because they are genuinely different products with different evidence. Standard-dose injections have the strongest evidentiary footing, since the approved products are injected and the route's absorption is well characterized. Microdose programs use the same route but market a sub-therapeutic dose whose efficacy isn't established — a pricing and marketing category more than a clinical one. Oral, ODT, and sublingual programs move the molecule to routes where a peptide's absorption is difficult and, for compounded products, generally uncharacterized. A price or claim about one form says nothing reliable about another, which is why no ranking on this site crosses those lines.
Cost and access
Captured advertised pricing for compounded tirzepatide varies more than threefold across providers, driven mainly by business model — all-inclusive bundling versus membership-plus-medication versus coaching-heavy programs — rather than by the drug itself. The comparable figure is effective monthly cost, which folds in mandatory memberships and fees; the price comparison ranks the captured programs on that basis with evidence statuses attached, and the true-cost calculator lets you normalize any specific offer. Access also depends on eligibility, state availability, and the individualized-clinical-need framework above. Manufacturer cash-pay and insurance pathways for the approved products are a separate class, covered in the brand-vs-compounded cost guide and never ranked against compounded programs.
Evidence and its limits
The efficacy evidence most people have heard about — the double-digit weight-loss percentages — comes from trials of the approved tirzepatide products at specific doses by injection. That evidence is strong and specific, and it's exactly why the approved products are the benchmark. What it does not do is transfer automatically to compounded preparations, to sub-therapeutic microdoses, or to oral and sublingual routes, each of which introduces its own unverified variables. Our research library summarizes the pivotal trials with their applicability limits stated study by study, and keeps compounded-formulation evidence — which is thin and largely observational — clearly separated from the approved-product evidence.
Frequently asked questions
Is compounded tirzepatide FDA approved?
No. No compounded tirzepatide is FDA approved, in any formulation. FDA approval applies to specific manufactured products, not to pharmacy-compounded preparations, which are made without premarket review of safety, effectiveness, or quality. Compounded tirzepatide is also not a generic. See the full explanation for the regulatory basis and what it means for evidence.
Is compounded tirzepatide a generic version of the brand?
No. A generic is itself FDA-approved and demonstrated to match a reference product; compounded tirzepatide is neither approved nor demonstrated equivalent. It's the same active ingredient prepared outside the approval system, with quality dependent on the individual pharmacy. Marketing that calls it a "generic" is inaccurate.
How much does compounded tirzepatide cost?
Captured advertised effective monthly costs vary more than threefold across providers, driven mainly by business model. The comparable figure is effective monthly cost including mandatory fees; see the price comparison for the captured programs with evidence statuses. All current figures are provider-reported, not checkout-verified, so treat them as advertised prices rather than confirmed totals.
Does the trial evidence apply to compounded tirzepatide?
Not automatically. The trials studied specific approved products at specific doses by injection; a compounded preparation's potency, consistency, and — for oral or sublingual forms — absorption aren't established by those trials. The evidence tells you what the molecule does at a known blood level; it doesn't confirm a compounded product reaches that level. Discuss what the evidence supports for your situation with a prescriber.